Product image unavailable

Carbamazepine

Vendor: Marketplace supplier

Formulations: - Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored) - Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 400 mg - Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored) Oral > Solid > capsule: 100 mg (extended-release); 200 mg (extended-release); 300 mg (extended-release) Indications: - Epilepsy or seizures - Bipolar or related disorders - Trigeminal neuralgia Source: EML workbook import

Product metadata will be available once the catalog entry is complete.

Kes0.00

VariantSupplierQuantity

Availability

Supplier and price will be confirmed during RFQ.

View Cart

Similar Products

Diazepam

Formulations: - Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube - Oral > Solid: 5 mg (scored); 2 mg (scored) - Oral > Liquid: 2 mg per 5 mL Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube Parenteral > General injections > unspecified: 5 mg per mL Oral > Solid > tablet: 5 mg (scored); 10 mg (scored); 2 mg (scored) Indications: - Status epilepticus - Anxiety - Palliative care Source: EML workbook import

MOQ: 1

Kes0.00

Ethosuximide

Formulations: - Oral > Liquid: 250 mg per 5 mL Oral > Solid: 250 mg Indications: - Absence seizures, typical Source: EML workbook import

MOQ: 1

Kes0.00

Lamotrigine

Formulations: - Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible) Indications: - Epilepsy or seizures Source: EML workbook import

MOQ: 1

Kes0.00

Levetiracetam

Formulations: - Oral > Liquid: 100 mg per mL Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial; 5 mg per mL in 100 mL bag; 10 mg per mL in 100 mL bag; 15 mg per mL in 100 mL bag Indications: - Epilepsy or seizures - Status epilepticus Source: EML workbook import

MOQ: 1

Kes0.00

Magnesium Sulfate

Formulations: - Parenteral > General injections > IV: 500 mg per mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume) Parenteral > General injections > IM: 500 mg per mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume) Indications: - Severe pre-eclampsia - Eclampsia Source: EML workbook import

MOQ: 1

Kes0.00

Midazolam

Formulations: - Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration) Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) - Oral > Liquid: 2 mg per mL Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) Oral > Solid > dosage form: 7.5 mg; 15 mg - Parenteral > General injections > IV: 1 mg per mL in 5 vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Oral > Liquid: 2 mg per mL Oral > Solid > dosage form: 15 mg; 7.5 mg Indications: - Status epilepticus - Palliative care - Sedative-hypnotic and anxiolytic drugs Source: EML workbook import

MOQ: 1

Kes0.00

Ready to amplify your rewards? Drop your email and we'll be in touch soon.